No abstract available
MeSH terms
-
Cardiovascular Diseases / chemically induced*
-
Celecoxib
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / adverse effects*
-
Cyclooxygenase Inhibitors / therapeutic use
-
Drug Approval / legislation & jurisprudence*
-
Gastrointestinal Hemorrhage / chemically induced
-
Gastrointestinal Hemorrhage / prevention & control
-
Humans
-
Isoxazoles / adverse effects
-
Lactones / adverse effects
-
Membrane Proteins
-
Prostaglandin-Endoperoxide Synthases
-
Publishing / standards
-
Pyrazoles / adverse effects
-
Randomized Controlled Trials as Topic / standards*
-
Research Design
-
Sulfonamides / adverse effects
-
Sulfones / adverse effects
-
United States
-
United States Food and Drug Administration / organization & administration*
Substances
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoxazoles
-
Lactones
-
Membrane Proteins
-
Pyrazoles
-
Sulfonamides
-
Sulfones
-
rofecoxib
-
valdecoxib
-
parecoxib
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Celecoxib